RPID 8-K SEC Filing Analysis

Latest settled — T+5d ⚠ clustered

RPID ▼ -10.78% at T+5d

SHORT call ✓ call won +10.78% · α vs SPY +10.06% · entry $2.32 → $2.07

Next anchor: T+20d tomorrow

Currently $1.88 · +18.97% from $2.32 entry (call sign-flipped)

Entry anchored
May 13, 2026
via day open

T+1d

-10.78%

call +10.78% · α +9.55%

$2.07

settled 27d ago

T+5d

-10.78%

call +10.78% · α +10.06%

$2.07

settled 21d ago

T+20d

—

call — · α —

—

tomorrow

T+60d

—

call — · α —

—

in 8w

Price Chart

Loading chart...

Executive Summary

Rapid Micro Biosystems reported Q1 2026 revenue of $8.0M (+11% YoY) and a net loss of $14.3M ($-0.31/share), wider than the $-0.25 consensus. While product revenue grew 36% and recurring revenue rose 28%, operating expenses surged 18% and cash burn accelerated. The company reaffirmed full-year 2026 guidance of $37-41M revenue and ~20% gross margins, but the widening loss and cash drain overshadow the top-line growth.

Key Financial Metrics

Guidance

$37.0M-$41.0M

maintained

Gross Margin

4.6%

Actionable Insight

The widening loss and rapid cash burn (~$15M/quarter) suggest the company may need to raise capital within 12 months. Monitor cash runway and any debt facility draws. The reaffirmed guidance provides a floor but the EPS miss and expense growth are negative signals for a pre-profit company.

Key Facts

Q1 2026 total revenue $8.0M, up 11% YoY from $7.2M
Net loss widened to $14.3M ($-0.31/share) vs $11.3M ($-0.26/share) in Q1 2025
EPS of $-0.31 missed consensus estimate of $-0.25 by 24%
Product revenue up 36% to $5.6M; recurring revenue up 28% to $5.1M (63% of total)
Total operating expenses increased 17.9% to $14.2M, with G&A up 30.8%
Cash, equivalents, and investments fell to $23.2M from $38.6M at year-end 2025
Reaffirmed FY2026 revenue guidance $37-41M and gross margin ~20%
Gross margin was 4.6% vs 5.6% in Q1 2025

Financial Impact

EPS miss of 24% ($-0.31 vs $-0.25 consensus) and cash burn of ~$15M in Q1

epsnet losscash positionoperating expenses

Risk Factors

Cash burn rate implies ~4 quarters of runway at current pace
Operating expenses growing faster than revenue (18% vs 11%)
Service revenue declined 22% YoY, signaling lumpy validation activity
Low gross margins (4.6%) limit operating leverage

Market Snapshot

Exchange

Nasdaq

Sector

Laboratory Analytical Instruments

Analyst Consensus

90% bullish (10 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

Document	Accession Number
8-K Filing (Primary)	0001380106-26-000067
Document: 0001380106-26-000067-index.html	0001380106-26-000067
Document: 0001380106-26-000067.txt	0001380106-26-000067
8-K Data (Synthetic)	0001380106-26-000067

5 reports for RPID

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for RPID — sortable, filterable
	Type				Now
May 19, 2026 21d ago	424B5 BEARISH ★ 7/10	$2.01 $2.02	▼ −0.50%	▲ +1.30%	$1.88 (+6.47%)
May 13, 2026 27d ago	8-K BEARISH ★ 6/10	$2.32 $2.07	▲ +10.78%	▲ +10.06%	$1.88 (+18.97%)
Apr 8, 2026 8w ago	DEFA14A NEUTRAL ★ 4/10	$2.12 $2.26	▲ +6.60%	▲ +3.42%	$1.88 (−11.32%)
Mar 12, 2026 12w ago	8-K NEUTRAL ★ 4/10	$3.43 $2.50	▼ −27.01%	▼ −26.03%	$1.88 (−45.11%)
Mar 12, 2026 12w ago	Press Release MIXED ★ 6/10	$3.43 $2.50	▼ −27.01%	▼ −26.03%	$1.88 (−45.11%)

US Market Status

Market Closed — Opens Thu (10h 31m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access